1 / 14

Part 6

Part 6. The Quintessential Quintet. Impaired Insulin Secretion. Islet b -cell. Increased HGP. Decreased Glucose Uptake. Decreased Incretin Effect. Increased Lipolysis. GLP-1 and GIP Responses in Type 2 Diabetes. NGT IGT T2DM.

bhite
Télécharger la présentation

Part 6

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Part 6

  2. The Quintessential Quintet Impaired Insulin Secretion Islet b-cell Increased HGP Decreased Glucose Uptake DecreasedIncretin Effect Increased Lipolysis

  3. GLP-1 and GIP Responses in Type 2 Diabetes NGT IGT T2DM Postprandial GLP-1 Levels Are Decreased in Patients withIGT and T2DM GIP Levels AreIncreased in T2DM * * 20 100 P<0.01 * * * Meal * * * * 80 * 15 60 GIP (pmol/L) 10 GLP-1 (pmol/L) 40 * 5 20 0 0 240 0 60 120 180 -30 0 60 120 180 210 Time (min) Time (min) *P<0.05.GLP-1=glucagon-like peptide-1; GIP=glucose-dependent insulinotropic polypeptide. Jones IR, et al. Diabetologia. 1989;32:668-677; Toft-Nielsen MB, et al. J Clin Endocrinol Metab. 2001;86:3717-3723.

  4. GLP-1, GIP, and Insulin AUC Across the Spectrum of Glucose Tolerance P<0.00005 P<0.05 16 4 P<0.005 12 14 3 10 12 8 10 2 AUC1 GLP-1 (nmol/L · min) 8 6 AUC1 GIP (nmol/L · min) AUC1 Insulin (mU/mL · min) 1 6 4 4 2 0 2 0 -1 0 -2 Controls NGT IGT T2DM Controls NGT IGT T2DM Controls NGT IGT T2DM Vaag AA, et al. Eur J Endocrinol. 1996;135:425-432.

  5. The Setaceous Sextet Impaired Insulin Secretion Islet a-cell Increased Glucagon Secretion Islet b-cell Increased HGP Decreased Glucose Uptake DecreasedIncretin Effect Increased Lipolysis

  6. Pancreatic -Cells and -Cells inNormal Individuals Cabrera O, et al. PNAS. 2006;103:2334-2339; Cleaver O, et al. In: Joslin’s Diabetes Mellitus. Lippincott Williams & Wilkins; 2005:21-39.

  7. Area of -Cells Is Increased inType 2 Diabetes P<0.05 -CellIslet Area(%) (n=10) (n=15) Clark A, et al. Diabetes Res. 1988;9:151-159.

  8. Basal Glucagon Levels and Basal HepaticGlucose Production in Type 2 Diabetes P<0.001 P<0.001 58% T2DM+ SRIF T2DM + SRIF 250 160 200 120 150 Plasma Glucagon (pg/mL) Basal HGP (mg/m2 • min) 80 100 40 50 44% 0 0 NGT T2DM NGT T2DM SRIF=somatostatin infusion. Baron A, et al. Diabetes. 1987;36:274-283.

  9. Hyperglucagonemia and Insulin-Mediated Glucose Metabolism Plasma Glucose (mmol/L) Plasma Insulin (mU/L) Plasma Glucagon (mU/L) Plasma FFA (mol/l) 0 24 48 hr 0 24 48 hr Del Prato S, et al. J Clin Invest. 1987;79:547-556.

  10. Inverse Relationship Between Insulin:Glucagon Ratio and Plasma Glucose in IGT 100 r=0.72 P<0.0001 r=-0.62 P<0.001 90 80 70 Glucose Appearance (mmol/5 hr) 60 50 40 12 15 6 8 10 14 0 5 10 20 Peak Postprandial Plasma Glucose Level (mmol/L) Plasma Insulin:Glucagon Ratio Yellow symbols=NGT; green symbols=IGT; circles=nonobese; squares=obese. Mitrakou A, et al. N Engl J Med. 1992;326:22-29.

  11. Abnormal Meal-Related Insulin and Glucagon Dynamics in Type 2 Diabetes Type 2 diabetes (n=12) Normal subjects (n-=11) Meal 360 330 300 Glucose (mg %) 270 240 110 80 120 90 Insulin (µU/mL) 60 Delayed/depressed insulin response 30 0 140 130 Nonsuppressed glucagon 120 Glucagon (pg/mL) 110 100 90 -60 0 60 120 180 240 Time (min) Müller WA, et al. N Engl J Med. 1970;283:109-115.

  12. The Septicidal Septet Impaired Insulin Secretion Islet a-cell Increased Glucose Reabsorption Islet b-cell Increased HGP DecreasedIncretin Effect Increased Lipolysis Increased Glucagon Secretion Decreased Glucose Uptake

  13. Renal Glucose Reabsorption in Type 2 Diabetes • Sodium-glucose cotransporter 2 (SGLT2) plays a role in renal glucose reabsorption in proximal tubule • Renal glucose reabsorption is increased in type 2 diabetes • Selective inhibition of SGLT2 increases urinary glucose excretion, reducing blood glucose Wright EM, et al. J Intern Med. 2007;261:32-43.

  14. Renal Handling of Glucose (180 L/day) (900 mg/L)=162 g/day Glucose SGLT2 S1 SGLT1 S3 90% 10% No Glucose

More Related